Proteaf and Flowid start cooperating
2013.07.02 News update by Flowid
A two sided agent agreement has been signed by Proteaf Technologies LCC and Flowid BV. Proteaf represents Flowid for the North American territory and vice versa.
Proteaf offers scalable application specific solutions based on off-the-shelf instrumentation supported by custom engineering and chemistry research and development services.
FlowFlex platform launched
2013.05.31 News update by Flowid
The FlowFlex is an automated modular continuous process development platform. The set-up is highly flexible in performing different kinds of flow chemistry based on different continuous technologies. All modules have the same dimensions and can be interconnected easily due to its uniform power, data and process interconnections.
For more information go to the FlowFlex product page.
SPIE Controlec Engineering BV and Flowid BV Sign Declaration of Intent
2012.09.21 Press release by Flowid
On Holland's largest three-masted schooner ‘De Eendracht’, SPIE Controlec Engineering and Flowid signed a declaration of intent to form a strategic alliance for the joint execution of projects.
The alliance foresees clear synergy effects for clients of both organizations when specific know-how and expertise is bundled. Initial focus will be on implementing spinning disc reactors. According to Auke de Leeuw, director of SPIE Controlec Engineering; it is a technology with huge potential and different applications in abundance. “This could be ‘the new revolution’ within the process industry”.
Flowid Extents Facilities
2012.08.17 Press release by Flowid
Flowid further extended their facilities on the campus of the Eindhoven University of Technology. The ‘Helix building’ could no longer meet Flowid’s demands. More office space and pilot hall facilities are required to support Flowid’s activities. Together with the Department of Chemical Reactor Engineering Flowid decided that keeping activities of both in close proximity of each other was favored over extending towards the new 'Catalyst' incubator building on the University campus.
The new offices are realized in the neighboring 'Matrix' building. These offices are renovated and equipped according to Flowid standards. All offices have a beautiful lookout over the pilot hall facilities. In July 2012 the movement started and in August 2012 it was completed.
While the telephone number and email addresses of Flowid are maintained, the visiting address has been changed to:
Den Dolech 2, Matrix 1.36-40
You are more than welcome to visit us in our new facilities!
Flowid and EmulTech realize unique platform for emulsification processes
2012.07.04 Press release by Flowid
The Eindhoven high-tech companies Flowid B.V. and EmulTech B.V. cooperated in the realization of a unique laboratorial platform for EmulTech’s ET4ME technology. This patented microfluidic technology is used for the development of drug delivery formulations with high degree of uniformity, solubility, tailored release, benign processes and reproducibility. Flowid succeeded in the design and realization of this platform in which all process critical equipment is combined in one compact and robust apparatus, easy to control, and ready to use in environments that meet pharmaceutical standards.
EmulTech B.V. called the ready to use platform ‘HercuTech’ and it will be part of their development projects for clients. By means of the HercuTech, thorough and fast research and development work can be performed to determine the process variables of the drug delivery formulations.
Flowid B.V. once again showed their capability to realize small and compact ‘skids’ in which large amounts of equipment is efficiently combined. Hereby, the ease of use is drastically being increased while reducing the wear on sensitive and expensive equipment.
Wessel Hengeveld, the Director Technology of Flowid, is pleased with the realization of the skid. “The well thought through design of the skid resulted in a system that fulfills all requirements of EmulTech and their clients. Besides the fact that it works exactly as foreseen, it also looks terrific and it’s easy to use. Flowid really showed their capability to realize small scale skids for laboratorial use.”
Robin de Bruijn, the CTO of EmulTech, adds: “The HercuTech platform really enables us to meet the demands of our clients and fulfill their needs. Now, EmulTech can perform feasibility studies even more flexible and even take the whole platform to the client on a simple and effective manner, ready for them to use it as well and experience the capabilities the ET4ME technology provides.”
EmulTech B.V. develops drug delivery systems using its superior microparticulate technology. This proprietary Emulsion Technology for Micro Encapsulates (ET4ME) is a highly versatile process, providing solutions to many current market demands, including uniformity, and reproducibility issues. The company is able to quickly test various formulations, requiring only small volumes and its parallel scale up strategy allows for swift and reproducible scale up.
Flowid B.V. is an engineering firm specialized in production scale implementation of continuous flow chemistry. Flowid offers solutions by providing a broad pallet of related expert services and specialized equipment. In the field of chemical technology Flowid has been awarded several times for its innovative and groundbreaking work.
Flowid is consortium partner in a grant from the Dutch Polymer Institute for the manufacturing of nanomedicines
2012.04.16 Press release by Flowid
Flowid B.V. is consortium partner in a grant that has been awarded by the Dutch Polymer Institute (DPI) to scale-up and optimize the manufacturing of CriPec® nanomedicines, a technology of Cristal Delivery B.V. The strong consortium is beeing completed with the expertise of PolyVation B.V., BioConnection B.V., and the Department of Pharmaceutics (Utrecht University).
The unique platform technology of transiently stable, polymeric nanoparticles called CriPec® is developed by Cristal Delivery. The nanoparticles have an exclusive position in the nanomedicinal field as they combine the best features of known nanoparticles into one tunable system.
The aim of the current project is to make substantial steps forward in the manufacturing and analysis of various intermediates and final polymeric nanomedicines, in order for the CriPec technology® to be ready for clinical development. For this, Flowid will convert the current method of formation to a scaled up continuous process. Besides Flowid and Cristal Delivery, the consortium is extended with other Dutch partners, experts in the field of polymer synthesis (PolyVation B.V.), filling & finishing (BioConnection B.V.) and characterization of nanomedicines (Utrecht University, Department of Pharmaceutics).
2012.04.01 Press release by Flowid
In 2012 Flowid will be exhibiting at the occaissions listed below. For more information please click the link or contact us.
18th until the 22nd of June Achema
2nd until the 5th of September ISCRE 22
26th until 27th of September Fourth Symposium on Continuous Flow Reactor Technology for Industrial Applications
7th until 8th of November MIFCAB1 in Jordan
Quantum Dot Continuous Flow Processing Breakthrough Achieved
2011.09.13 Press release by Quantum Materials Corporation
With this advance, researchers and manufacturers have the opportunity to now incorporate Quantum Materials Tetrapod Quantum Dots into new state-of-the-art electronics products that require industrial scale amounts of material.
This new quantum dot production process using a new microreactor and software controlled continuous flow process has been successfully developed and operated for delivery of mass produced quantum dots by Quantum Materials Corporation and the Access2Flow Consortium of The Netherlands. It replaces batch synthesis and has potential for high improvement in both yield and conversion. Tetrapod Quantum Dots are used in a variety of emerging applications including solid state lighting, QLED displays, nanobio applications and are proven to have superior performance characteristics surpassing spherical nanoparticles. This process will also be used for QMC’s subsidiary, Solterra Renewable Technologies' solar cells and solar panels.
The inherent design of the microreactor allows for commercial-scale parallel modules to achieve large production rates at low cost in a regulated, optimized system. This breakthrough production process provides flexibility in the choice of materials used to produce the quantum dots including heavy metal free (Cadmium Free) quantum dots and other biologically inert materials. Quantum dots have been widely recognized for their potential in next generation display technologies, solar cells, LEDs, OLEDs, computer memory, printed electronics and a vast array of security, biomedical and energy storage applications. According to research group BCC Research, the 2010 global market for quantum dots was estimated $67 million in revenues, and is projected to grow quickly over the next 5 years at greater than 50% per year reaching almost $670 million by 2015.
Quantum Materials offers to manufacturers that it is now realistic to test the advantages of quantum dots to establish higher performance benchmarks across a number of industries and product applications. Many discoveries have literally been held back by the difficulty in manufacturing quantum dots, the lack of quality and uniformity of quantum dots, and the corresponding high cost, with the current average cost of quantum dots running being between $2500 and $6000/gram. This technology removes the roadblock from widespread adoption of the quantum dot as a basic building block of technology and services much like the silicon chip that has ubiquitously advanced corporate function and consumer lifestyles worldwide.
”Our goal from the onset has been to achieve a production rate of 100kg per day with a 95% or greater yield,” according to Stephen Squires, Founder and CEO of Quantum Materials Corporation. He added that “with this breakthrough QMC has coupled two disruptive technologies resulting in the potential to now achieve that goal.” According to QMC’s Chief Technical Officer, Dr. Bob Glass “Besides the scalability indicated, in my opinion, the truly remarkable accomplishment in this breakthrough is its adaptability to other inorganic metals and elements, including cadmium-free Quantum Dots.”